Whole Body Vibration Therapy in Individuals With Type 2 Diabetes
The Effect of Whole Body Vibration Therapy on Muscle Oxygenation in Individuals With Type 2 Diabetes: A Randomized Controlled Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this interventional study is to investigate the effect of whole body vibration therapy on muscle oxygenation, vibration sensation, functional capacity and balance in individuals with Type 2 diabetes. The main questions aimed to be answered are:
- Does whole body vibration therapy affect peripheral muscle oxygenation?
- Does whole body vibration therapy improve vibration sense, functional capacity and balance compared to aerobic exercise? Participants' muscle oxygenation, vibration sensation, functional capacity and balance parameters will be assessed. They will participate in a whole body vibration therapy or aerobic training program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started Aug 2025
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2025
CompletedFirst Posted
Study publicly available on registry
June 3, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedAugust 26, 2025
August 1, 2025
4 months
May 17, 2025
August 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle Oxygenation
Vastus lateralis muscle oxygenation will be evaluated with Near-Infrared Spectroscopy at rest, during and after the 6-Minute Walk Test (6MWT)
8 weeks
Secondary Outcomes (5)
Vibration sense
8 weeks
The Timed Up & Go Test
8 weeks
The 6 minute walk test
8 weeks
The 30-second Chair Stand Test
8 weeks
Balance
8 weeks
Study Arms (2)
Aerobic Exercise
EXPERIMENTALThe aerobic exercise group (AE) will participate in an ascending aerobic exercise program for 8 weeks, 3 sessions per week.
Whole Body Vibration
EXPERIMENTALThe whole body vibration group (AE+TVV) will additionally participate in an 8-week incremental aerobic exercise program of 3 sessions per week.
Interventions
Each exercise session will be performed with a frequency of 30 Hz and an amplitude of 2 mm. Participants are in a 110° squat position on the platform (the degree will be adjusted using a goniometer). Participants will exercise for 16 minutes from week one to week three, 20 minutes from week four to week six and 24 minutes from week seven to week eight, respectively (8 iterations and 1 minute of vibration with 1 minute interval between each iteration)
From week one to week three, from week four to week six and from week seven to week eight, the participants will exercise for 30 minutes (5 minutes of running at 60-70% of heart rate and 5 minutes of active rest at 30-45% of maximum heart rate), 42 minutes (7 minutes of running at 60-70% of heart rate and 7 minutes of active rest at 30-45% of maximum heart rate) and 60 minutes (10 minutes of running at 60-70% of heart rate and 10 minutes of active rest at 30-45% of maximum heart rate). The exercise sessions consist of warm-up, main program and cool-down phases.
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the research
- Being diagnosed with type 2 diabetes
- years of age or older
- HbA1c level to be 6.5-10%
- Having a clinical history of diabetes between 2-10 years
- Receiving oral hypoglycemic agent treatment
- At least three HbA1c measurements within 12 to 24 months
- Hemoglobin variability score (HVS) \<50
- Being able to walk independently
- Mini mental test score ≥ 24
- Vastus lateralis muscle adipose tissue thickness \<20mm
- BMI \<30 kg/m2
You may not qualify if:
- Previous or concurrent psychiatric, neurological, orthopedic or systemic illness
- Use of insulin in treatment
- Diabetic neuropathy
- Foot ulcer
- Participation in any exercise program in the last 6 months
- History of major hypoglycemia in the last 12 months
- Working or have worked in a job with high exposure to mechanical whole body vibrations
- Conditions that may contraindicate whole body vibration (deep vein thrombosis, severe osteoporosis, active cancer, implanted medical devices, etc.)
- Hearing, vision and perception problems that may affect research results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ankara Medipol Universitylead
- Gazi Universitycollaborator
Study Sites (1)
Gazi University, Faculty of Health, Department of Physiotherapy and Rehabilitation
Ankara, Çankaya, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The study is planned as a triple-blind, randomized controlled trial. Patients will not be informed about their group. The assessment will be followed by 1 physiotherapist, and the exercise program will be followed by 2 physiotherapists (the physiotherapist performing the assessment is not included). Study groups will be coded before statistical analysis, and the meaning of the codes will not be told to the statistician.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 17, 2025
First Posted
June 3, 2025
Study Start
August 1, 2025
Primary Completion
December 1, 2025
Study Completion
December 31, 2025
Last Updated
August 26, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share